Professor Mara Kyrgiou is a Professor in Gynaecologic Oncology at Imperial College London and Imperial College NHS Trust. She has trained in obstetrics and gynaecology and subsequently specialised in minimal access and gynaecologic oncology surgery at the West London Gynaecological Cancer Centre at Imperial College Healthcare NHS Trust. The main focus of her academic interests has been in translational research in gynaecological diseases and cancers, in particular cervical and endometrial cancer. She has investigated the role of treatment of cervical cancer and precancer on reproductive outcomes and genetic and epigenetic determinants of cervical disease. She has developed an interest on the role of microbiome and host interactions in gynaecological cancer. She works on the role of obesity and metabolic disorders in endometrial cancer. She is the chief investigator of the NOVEL trial assessing the value of HPV vaccination after conisation for CIN. Professor Kyrgiou contributes to a number of national and international committees, such as the ESGO Prevention Committee.